FAP and cancer: The precise molecular mechanisms linking DPP-IV inhibition and various beneficial effects, including the prevention of cancer initiation and the protection of healthy tissues from the toxic effects of chemotherapy, remain largely unknown, but likely include the increased signaling of DPP-IV substrates, such as CXCL12.